Skip to main content
. 2025 Nov 28;22(11):922–929. doi: 10.26599/1671-5411.2025.11.005

Table 6. Kaplan–Meier Survival Analysis Stratified by Sarcopenia Status.

Cohort Median Follow-up (days) IQR (days)
Median follow-up was shorter in sarcopenic patients compared to non-sarcopenic patients. A log-rank test demonstrated a statistically significant difference in survival distributions between the two groups (χ2 = 6.13, P = 0.0133), indicating worse long-term survival among sarcopenic patients. IQR: interquartile ranges. This table summarizes the median follow-up times and interquartile ranges (IQR) for sarcopenic and non-sarcopenic patients, as well as for the overall cohort.
Sarcopenic 809.0 350.0–1403.0
Non-Sarcopenic 1244.0 518.5–1993.5
Overall Cohort 984.5 442.8–1845.5
Log-rank test χ² = 6.13 P = 0.0133